Subscribe

DCI Blog

All
All

Duke Cancer Institute (DCI) Blog provides updates, organizational announcements, the latest in funding opportunities and information on upcoming conferences and symposiums. This blog also highlights inspiring patient stories and the accomplishments and achievements of DCI faculty and staff. Subscribers are invited to submit story ideas and other news of interest. Email submissions and feedback to Karen E. Butler, Director of Communications, Duke Cancer Institute.

Patz’s Human-Derived Antibody Treatment Moves Forward

Patz's Human-Derived Antibody Treatment Moves Forward With Boost from NCI and Manufacturing Agreement Grid Therapeutics, LLC, a new start-up company led by Duke Cancer Institute cardiothoracic radiologist Edward Patz, Jr., MD , has developed and is on track to manufacture and bring to trial what it...

August Newsmakers

Read here for a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work was featured in the media and academic journals this month. This list includes Tian Zhang, MD; Arif Kamal, MD, MHS; Kim Slusser, MSN, BSN; Fumiko Chino, MD; and many others.

July Newsmakers

Read here for a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work was featured in the media and academic journals this month. This list includes Henry Friedman, MD. Edward F. Patz, Jr, MD; Julie Sosa, MD and many others.

May Newsmakers

Read here for a sample of some of the DCI physicians, physician-scientists and researchers whose work was featured in the media and academic journals this month. This list features the Preston Robert Tisch Brain Tumor Center, and also includes Yousuf Zafar, MD and many more.

Antibody Preferentially Attacks Cancer Cells

A research team from Duke Health has developed an antibody from the body’s own immune system that preferentially attacks cancer cells. The antibody works by targeting a natural defense mechanism that cancer tumors exploit. Cells in the body essentially use a home security system that relies on...

April Newsmakers

Read here for a sample of some of the DCI physicians, physician-scientists and researchers whose work was featured in the media and academic journals this month. This list includes Daniel S. Wechsler, MD, PhD; Annick Desjardins, MD, PhD; Thomas D'Amico, MD; and many more.

High-Risk Lung Cancer Patients

Most high-risk lung cancer patients might not need annual low-dose computed tomography (LDCT) screenings if they are cleared of disease in their initial test, according to a study led by a Duke Cancer Institute researcher. The researchers found that even former heavy smokers appear to have a...